Addenbrooke's Hospital is an internationally renowned teaching hospital and research centre in Cambridge, England, with strong affiliations to the University of Cambridge. Addenbrooke's Hospital is based on the Cambridge Biomedical Campus.

There are 1,000 beds in Addenbrookes Hospital.

During the past decade, Addenbrookes Hospital conducted 415 clinical trials. In the 10-year time frame, 415 clinical trials started and 122 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 129 clinical trials started and 68 clinical trials were completed. i.e. 52.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Addenbrookes Hospital" #1 sponsor was "Cambridge University Hospitals NHS Foundation Trust" with 99 trials, followed by "University College, London" with 34 trials sponsored, "Children's Cancer and Leukaemia Group" with 33 trials sponsored, "University of Cambridge" with 24 trials sponsored and "Hoffmann-La Roche" with 24 trials sponsored. Other sponsors include 549 different institutions and companies that sponsored additional 284 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Addenbrookes Hospital" #1 collaborator was "Cambridge University Hospitals NHS Foundation Trust" with 44 trials as a collaborator, "Cancer Research UK" with 39 trials as a collaborator, "University of Cambridge" with 38 trials as a collaborator, "AstraZeneca" with 21 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 17 trials as a collaborator. Other collaborators include 770 different institutions and companies that were collaborators in the rest 496 trials.

According to Clinical.Site data, the most researched conditions in "Addenbrookes Hospital" are "Breast Cancer" (30 trials), "Prostate Cancer" (26 trials), "Ovarian Cancer" (23 trials), "Brain and Central Nervous System Tumors" (19 trials) and "Melanoma" (14 trials). Many other conditions were trialed in "Addenbrookes Hospital" in a lesser frequency.

Most popular intervention types in "Addenbrookes Hospital" are "Drug" (471 trials), "Other" (116 trials), "Biological" (102 trials), "Procedure" (98 trials) and "Radiation" (73 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (97 trials), "radiation therapy" (38 trials), "cyclophosphamide" (31 trials), "adjuvant therapy" (27 trials) and "cisplatin" (24 trials). Other intervention names were less common.

The vast majority of trials in "Addenbrookes Hospital" are 660 trials for "All" genders, 54 trials for "Male" genders and 52 trials for "Female" genders.

Currently, there are 258 active trials in "Addenbrookes Hospital". 8 are not yet recruiting, 147 are recruiting, 99 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 317 completed trials in Addenbrookes Hospital, 3 suspended trials, and 57 terminated clinical trials to date.

Out of the total trials that were conducted in Addenbrookes Hospital, 66 "Phase 1" clinical trials were conducted, 228 "Phase 2" clinical trials and 266 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 125 trials that are defined as “Not Applicable".

Addenbrookes Hospital has several departments that took part in Clinical trials: "Addenbrookes Hospital; Dept of Oncology" - 3 trials, "Addenbrookes Nhs Trust; Oncology Clinical Trials Unit" - 3 trials, "Lysosomal Disorders Service, Addenbrookes Hospital NHS Trust" - 2 trials, "Addenbrooke'S Hospital; Rheumatology Research Unit" - 3 trials, "Department Of Neurosciences, Addenbrookes Hospital" - 2 trials, "Addenbrooke's Hospital, Department of Vascular Surgery" - 2 trials, "Addenbrooke's Hospital, Department of Gastroenterology" - 2 trials